Profile of pterostilbene-induced redox homeostasis modulation in cardiac myoblasts and heart tissue

Abstract

This study was designed to investigate the effect of pterostilbene (PTS) on cardiac oxidative stress in vitro, as this is a simple and promising methodology to study cardiac disease. Cardiac myoblasts (H9c2 cells) and homogenised cardiac tissue were incubated with the PTS and cyclodextrin (PTS ? HPbCD) complex for 1 and 24 h, respectively, at concentrations of 50 lM for the cells and 25 and 50 lM for cardiac tissue. The PTS ? HPbCD complex was used to increase the solubility of PTS in water. After the pretreatment period, cardiomyoblasts were challenged with hydrogen peroxide (6.67 lM) for 10 min, while cardiac tissue was submitted to a hydroxyl radical generator system (30 min). Cellular viability, oxidative stress biomarkers (e.g. total reactive oxygen species (ROS), carbonyl assay and lipoperoxidation) and the antioxidant response (e.g. sulfhydryl and the antioxidant enzyme activities of superoxide dismutase, catalase and glutathione peroxidase) were evaluated. In cardiomyoblasts, the PTS ? HPbCD complex (50 lM) increased cellular viability. Moreover, the PTS ? HPbCD complex also significantly increased sulfhydryl levels in the cells submitted to an oxidative challenge. In cardiac tissue, lipid peroxidation, carbonyls and ROS levels were significantly increased in the groups submitted to oxidative damage, while the PTS ? HPbCD complex significantly reduced ROS levels in these groups. In addition, the PTS ? HPbCD complex also provoked increased catalase activity in both experimental protocols. These data suggest that the PTS ? HPbCD complex may play a cardioprotective role through a reduction of ROS levels associated with an improved antioxidant response.

Pterostilbene Interferes With Lipopolysaccharide-Induced Myocardial Injury Through Oxidative Stress and Inflammasome Pathways

“…The concentration of collagen in the heart tissue is significantly increased ( Yin et al, 2012 ; Han et al, 2017 ). PTS has been shown to inhibit or reduce the production of fibrosis in myocardial ischemia and reperfusion, liver injury and lung injury ( Lv et al, 2015 ; Couto et al, 2018 ; Kosuru et al, 2018 ; Lacerda et al, 2020 ; Zhang et al, 2021 ). In this article, we found that the fibrosis level in the myocardial tissue after PTS treatment has been effectively controlled by the fibrosis markers collagen I and collagen III and Masson.…”

Melatonin attenuates AFB1-induced cardiotoxicity via the NLRP3 signalling pathway

“…Generation of reactive oxygen species (ROS) was estimated with the fluorescent probe 2,7-dichlorodihydrofluorescein diacetate (DCFHDA), as previously described. 20 , 21 For each sample, levels of ROS were expressed in terms of DCF fluorescence generation/ mg protein/ min.…”

Pterostilbene protects against H2O2‐induced oxidative stress by regulating GAS6/Axl signaling in HL‐1 cells

“…PTE has also been shown to be a potent antioxidant drug against various diseases, such as pulmonary fibrosis and cerebral ischemia‐reperfusion 7,8 . Furthermore, several preclinical investigations have also explored PTE's potential in preventing cardiac disorders 9‐11 . These findings underscores PTE's heightened potency as a modulator of cardioprotection.…”